Cafizetamol Forte

Description

CAFIZETAMOL FORTE is a pharmaceutical product identified by NDC 69729-147-40. It is formulated as a dosage form of 40 caplets, designed for the management of pain, cold symptoms, and fever. The product is intended for use in providing superior relief in these conditions.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with headache and muscular aches.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are advised to take 2 caplets every 6 hours as needed. The total daily dosage should not exceed 6 caplets within a 24-hour period. For children under 12 years of age, it is recommended to consult a physician for appropriate dosing guidance. It is imperative that the recommended dosage is not exceeded to ensure safety and efficacy.

Contraindications

Use of this product is contraindicated in patients who are concurrently taking any other drug containing acetaminophen, whether prescription or nonprescription. Due to the potential for acetaminophen overdose, it is essential to consult a healthcare professional, such as a doctor or pharmacist, before combining this product with any other medications.

Warnings and Precautions

This product contains acetaminophen, which poses a risk of severe liver damage under certain conditions. Healthcare professionals should advise patients to adhere strictly to the following guidelines to mitigate this risk:

• The maximum recommended dosage is 6 caplets within a 24-hour period. Exceeding this limit may lead to severe liver injury.

• Patients should avoid concurrent use of other medications containing acetaminophen to prevent unintentional overdose.

• Consumption of three or more alcoholic drinks daily while using this product is contraindicated, as it significantly increases the risk of liver damage.

Caffeine content in this product is comparable to that found in a standard cup of coffee. Therefore, it is advisable to limit the intake of additional caffeine-containing medications, foods, or beverages during treatment. Excessive caffeine consumption may result in adverse effects such as nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat.

General precautions should be taken into account prior to use. Patients with a history of liver disease should consult a healthcare provider before starting this product. Additionally, individuals taking the anticoagulant warfarin should seek advice from a doctor or pharmacist to ensure safe concurrent use.

In the event of an overdose, immediate medical assistance is crucial. Patients or caregivers should contact a Poison Control Center or seek emergency medical help without delay, regardless of the presence of symptoms, as prompt intervention is essential for both adults and children.

Patients are advised to discontinue use and consult a healthcare professional if any of the following occur:

• The emergence of new symptoms.

• Existing symptoms do not improve or worsen.

• The painful area exhibits redness or swelling.

• Pain persists or intensifies beyond 10 days.

• Fever worsens or lasts longer than 3 days.

Side Effects

Severe liver damage may occur in patients taking this product containing acetaminophen if they exceed the maximum daily amount of 6 caplets within 24 hours, use it concurrently with other drugs containing acetaminophen, or consume 3 or more alcoholic drinks daily while using this product. Patients are advised to limit the use of caffeine-containing medications, foods, or beverages, as the recommended dose of this product contains approximately the same amount of caffeine as a cup of coffee. Excessive caffeine intake may lead to symptoms such as nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.

Patients should not use this product in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription, and are encouraged to consult a doctor or pharmacist if they are uncertain about other medications. Individuals with liver disease should seek medical advice before using this product. Additionally, patients taking the blood-thinning medication warfarin should consult a healthcare professional prior to use.

Patients are instructed to discontinue use and seek medical advice if any new symptoms arise, if symptoms do not improve or worsen, if the painful area becomes red or swollen, if pain persists for more than 10 days, or if fever worsens or lasts for more than 3 days. In the event of an overdose, it is critical for patients to obtain medical help or contact a Poison Control Center immediately, as prompt medical attention is essential for both adults and children, even in the absence of noticeable signs or symptoms.

Drug Interactions

Concurrent use of this product with any other medications containing acetaminophen, whether prescription or nonprescription, is contraindicated due to the risk of acetaminophen overdose and potential hepatotoxicity.

Patients taking the anticoagulant warfarin should consult with a healthcare professional prior to using this product. The combination may necessitate careful monitoring of INR levels to avoid increased bleeding risk.

Additionally, it is advisable to limit the intake of caffeine-containing medications, foods, or beverages while using this product. Excessive caffeine consumption may lead to adverse effects such as nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat. Monitoring for these symptoms is recommended to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Cafizetamol Forte (acetaminophen, caffeine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 2 caplets every 6 hours, with a maximum of 6 caplets in a 24-hour period.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. Severe liver damage may occur if patients exceed the maximum daily dosage of 6 caplets within a 24-hour period. Additionally, patients should avoid concomitant use with other medications containing acetaminophen, as this may further increase the risk of liver injury.

It is also advised that patients limit alcohol consumption to fewer than 3 drinks per day while using this product, as alcohol can exacerbate the potential for liver damage.

Before initiating treatment, patients with known liver disease should consult a healthcare professional to assess the appropriateness of this product for their condition. Monitoring of liver function may be warranted in these patients to ensure safety and efficacy during treatment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt medical intervention is crucial for both adults and children, even in the absence of observable signs or symptoms.

Healthcare professionals are advised to remain vigilant and proactive in managing potential overdose situations. The lack of immediate symptoms does not preclude the possibility of serious health consequences, and therefore, timely evaluation and treatment are essential.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert for CAFIZETAMOL FORTE.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose, emphasizing the importance of prompt medical attention for both adults and children, even if no signs or symptoms are apparent.

Patients should be informed not to use this medication in conjunction with any other products containing acetaminophen, whether prescription or nonprescription. It is recommended that patients consult with a doctor or pharmacist before using this medication alongside any other drugs if they are uncertain.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they experience any new symptoms, if their symptoms do not improve or worsen, or if the area of pain becomes red or swollen. Additionally, patients should be advised to stop use and seek medical advice if their pain intensifies or persists for more than 10 days, or if their fever worsens or lasts longer than 3 days.

Patients with liver disease should be encouraged to consult a doctor prior to using this medication. Furthermore, those taking the blood-thinning medication warfarin should be advised to speak with a doctor or pharmacist before use to ensure safety and avoid potential interactions.

Storage and Handling

The product is supplied in a configuration that includes a tamper-evident safety seal. It is essential to ensure that the safety seal under the cap is intact; the product should not be used if the seal is broken or missing.

Storage conditions require the product to be maintained at a controlled room temperature of 20° to 25°C (68° to 77°F). Proper handling and storage are crucial to preserve the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is 2 caplets every 6 hours, with a maximum of 6 caplets in a 24-hour period. For children under 12 years of age, it is advised to consult a doctor for appropriate dosing guidance.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cafizetamol Forte, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)